Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000813

Director sold 22,781 shares at an average $19.42 ($442,403)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-24 Sale : show line 1 in the form −7,868 $19.23 $151,302 2,054,283 I
2017-08-25 Sale : show line 2 in the form −14,913 $19.52 $291,102 2,039,370 I
Open-market sales · 22,781 sh · avg $19.42 · $442,403
Loading xslF345X03/vonemster_fm4aug242017.xml…